Peterson, Tess E.
Landon, Christian
Haberlen, Sabina A.
Bhondoekhan, Fiona
Plankey, Michael W.
Palella, Frank J.
Piggott, Damani A.
Margolick, Joseph B.
Brown, Todd T.
Post, Wendy S.
Wu, Katherine C.
Funding for this research was provided by:
National Institutes of Health (T32 HL007227, K24 AI120834)
National Heart, Lung, and Blood Institute (R01 HL126552, R01 HL126552, R01 HL126552, R01 HL126552)
Article History
Received: 5 July 2022
Accepted: 26 August 2022
First Online: 3 September 2022
Declarations
:
: This study was approved by the Institutional Review Board of the Johns Hopkins University School of Medicine and was conducted in accordance with the declaration of Helsinki. Written informed consent was obtained from all subjects.
: Not Applicable.
: TTB has served as a consultant to Janssen, ViiV Healthcare, Gilead Sciences, Merck, and Theratechnologies. Other authors declare that they have no competing interests.